首页|体外生物转化(ivBT):生物制造的新前沿

体外生物转化(ivBT):生物制造的新前沿

扫码查看
人类社会的重大挑战(如粮食安全、能源安全、气候变化与双碳目标等)驱动全社会寻求创新型技术解决方案.体外生物转化(invitro biotransformation,ivBT)是介于微生物发酵与酶催化之间的新质生物制造平台,多酶分子机器是其超限生物催化剂.它基于大道至简原则,利用多个天然酶、人工酶以及(仿生/天然)辅酶等重构生化途径,摆脱生物体生存局限(如细胞复制、基础代谢、复杂调控和能量供给等),超越细胞合成极限,实现重要生物转化与超限能量转换,尤其是生产低值大宗产品与新能源产品等.工业生物制造的三个平台技术分别是基于细胞工厂的发酵、基于酶分子的生物催化与基于多酶分子机器的ivBT.本综述对ivBT给出明确定义,阐明其多酶途径设计原则与产业化技术研发路径,比较该平台与现有生物制造平台相似性与不同点,介绍多个代表性案例,以及讨论其未来的机会与挑战.ivBT技术发展采用设计-构建-判决-优化的线性策略,开发能够满足国家需求的超高效多酶分子机器.利用ivBT有望形成超过30万亿元生物产品的工业生物制造,助力实现人类社会的多项重要需求,如粮食安全、新型能源体系等.人造淀粉不仅可以帮助中国端牢粮食饭碗,而且将是一个全新且安全的高密度储氢载体(比压缩氢气高2.5倍)与高能储电介质(比锂电池高10倍).
In vitro BioTransformation(ivBT):a new frontier of industrial biomanufacturing
Huge challenges,such as food security,energy security,climate change,dual-carbon target,and so on,motivate human society to seek disruptive and innovative solutions.In vitro biotransformation(ivBT),bridging the gap between whole-cell-based fermentation and enzyme-based biocatalysis,is an emerging biomanufacturing platform designed for the production of biocommodities(e.g.,synthetic starch,healthy sweeteners,organic acids,etc.)and bioenergy.In ivBT,in vitro synthetic enzymatic biosystem(ivSEB)is its high-efficiency biocatalyst.Based on the Chinese philosophy that"Tao is simple",ivSEB is the in vitro reconstruction of artificial(non-natural)enzymatic pathways with a number of natural enzymes,artificial enzymes,and/or(biomimetic or natural)coenzymes,and/or artificial membrane,without living cell's constraints,such as cell duplication,bioenergetics,basic metabolisms,regulation,and so on.ivBT enables it to surpass the limitations of whole-cell fermentation and has multiple advantages,such as theoretical product yield,at least 10-time volumetric productivity,tolerance to toxic substrate/product,and so on.This review defines the concept of ivBT,presents its design principles,distinguishes it from other seemingly-like concepts,such as cell-free protein synthesis and cascade enzyme biocatalysis,introduces several representative examples,and discusses its challenges and opportunities.The development of ivBT is based on the linear strategy of"Design-Build-GoNG-Optimization",leading to super-biomanufacturing machines that can meet national needs,such as food security and new energy system.To address food security,we propose two out-of-the-box solutions:(1)in vitro biotransformation of cellulose to starch,possibly increasing the starch supply by a factor of 10;(2)artificial starch synthesis from CO2 by combining ivBT and chemical catalysis.Furthermore,the revolutionary production of starch could open a door to the starch-based carbohydrate economy,wherein starch is a high-density hydrogen carrier,more than 2.5 times that of compressed hydrogen,and an ultra-high electricity storage compound,more than 10 times of lithium-ion battery.In a word,ivBT featuring ultra-high energy efficiency and potentially-low-cost production could become a third industrial biomanufacturing platform and help solve huge challenges.

in vitro synthetic biologyindustrial biomanufacturingin vitro biotransformationin vitro synthetic enzymatic biosystemfood security

石婷、宋展、宋世怡、张以恒

展开 >

中国科学院天津工业生物技术研究所低碳合成工程生物学(全国)重点实验室,天津 300308

中国科学院天津工业生物技术研究所体外合成生物学中心,天津 300308

合成生物学海河实验室,天津 300308

上海交通大学生命科学技术学院,微生物代谢国家重点实验室,上海 200240

华东理工大学生物反应器工程国家重点实验室,上海 200237

展开 >

体外合成生物学 工业生物制造 体外生物转化 多酶分子机器 粮食安全

2024

合成生物学

合成生物学

CSTPCD北大核心
ISSN:
年,卷(期):2024.5(6)